USask VIDO-InterVac research team. (Photo: University of Saskatchewan)

Promising pre-clinical results for USask VIDO-InterVac COVID-19 vaccine

Posted on

A COVID-19 vaccine candidate developed by the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) has cleared another major milestone in moving towards human clinical trials: the novel vaccine has proven highly effective in ferrets, one of the commonly used animal models for COVID-19….

https://news.usask.ca/articles/research/2020/promising-pre-clinical-results-for-usask-vido-intervac-covid-19-vaccine.php

Read More Impact Stories

Posted on
McGill-developed device offers 100 per cent accuracy in as little as 10 minutes, and can be configured to detect a [...]
Posted on
This content is available in French only.
Posted on
The University of Toronto and Moderna, Inc. known for its mRNA-based COVID-19 vaccine plan to work together to develop new [...]